What is the current share price of Anthem Biosciences Limited (ANTHEM)?

As of the latest market update, Anthem Biosciences Limited (ANTHEM) is trading at ₹754.7. The stock has moved 0.36% up in the recent session.

What is the technical sentiment for ANTHEM stock?

Based on our proprietary technical analysis, the current signal for ANTHEM is "NEUTRAL". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Anthem Biosciences Limited?

Anthem Biosciences Limited has seen a 52-week high of ₹873.5 and a 52-week low of ₹579.15. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Anthem Biosciences Limited belong to?

Anthem Biosciences Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of ANTHEM?

Anthem Biosciences Limited (ANTHEM) has a market capitalization of approximately ₹42.39K Cr. This classifies it as a mid cap stock in the Indian market.

ANTHEM

NSE

Anthem Biosciences Limited (MID CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Biotechnology

₹754.70

2.70 (0.36%)

Medium VOLATILITY

As on 10 Jul 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹42.39K Cr

MID CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

71.6

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Biotechnology

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹579.15+30.3%

52W High₹873.5-13.6%

Current Price

₹754.70

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹603.76

Upper Circuit₹905.64

Reference Price

₹754.70

Investment Checklist

Inverse Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹840.8

Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹728.9

20/50 Bearish Cross detected 3 day(s) ago

MACD(12,26,9): Bearish crossover, Downward trend (below zero). Hist: shrinking (fading momentum)

SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Analysis from 2026-07-10

Confidence

44%

Trend

NEUTRAL

Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)

EMA20

766.12

EMA50

760.01

EMA200

732.78

Price Action

MIXED

NEUTRAL

Higher Highs3

Higher Lows4

Lower Highs6

Lower Lows5

Support & Resistance Levels

Resistance (Above)

₹785.90

₹803.02

₹814.80

₹825.65

₹865.47

Support (Below)

₹749.74

₹736.15

₹709.52

₹690.45

₹677.00

Volume Analysis

TrendDECREASING

Change-20.40%

Unusual VolumeNo

Recent MA Crossovers

20/50 Bearish Cross

3 days ago

SELL

Stop Loss Levels

Fixed Risk

1% Risk₹747.15

3% Risk₹732.06

5% Risk₹716.97

7% Risk (Custom)

₹701.87

Technical Levels

1x ATR (Volatility)₹734.10

2x ATR (Swing)₹713.50

3x ATR (Trend)₹692.90

Immediate Support₹749.74

Moving Averages

EMA 200 (Long-term)₹732.78

Financials

Financial Analysis

Metric	Dec '24	Mar '25	Sep '25	Dec '25
Revenue	₹497.8 Cr	₹483.2 Cr	₹550 Cr	₹423.2 Cr
Net Profit	₹124.3 Cr	₹82.6 Cr	₹173.4 Cr	₹92.8 Cr
EPS	₹2.22	—	₹3.09	₹1.65
Operating Profit	₹183.9 Cr	₹208.9 Cr	₹266.1 Cr	₹165.4 Cr

Peer Comparison

Biotechnology

Peer Comparison

Symbol	Name	Price	Change	P/E Ratio	Market Cap
ANTHEM	Anthem Biosciences Limited	₹754.70	+0.36%	71.6	₹42.39K Cr mid Cap
ADVENZYMES	Advanced Enzyme Technologies Limited	₹329.85	+1.70%	20.9	₹3.69K Cr small Cap

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All

Ex Date	Purpose	Type
25 Jun 2026	Dividend - Rs 2 Per Share	DIVIDEND

Announcements

Latest updates

View All

Date	Description	Link
10 Jul 2026	Certificate under SEBI (Depositories and Participants) Regulations, 2018
08 Jul 2026	Disclosure under SEBI Takeover Regulations
08 Jul 2026	Updates
03 Jul 2026	Credit Rating
03 Jul 2026	Reply to Clarification- Financial results

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
19 May 2026	Board Meeting Intimation	XBRL
19 May 2026	Financial Results/Dividend
05 Feb 2026	Financial Results
05 Feb 2026	Board Meeting Intimation	XBRL
08 Nov 2025	Financial Results

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 2 Qtrs)

Latest News

News for ANTHEM

View All

IOC Allows Russia's Olympic Return While Retaining Flag And Anthem Ban

negative

NDTV Profit 3d ago

IOC Allows Russia's Olympic Return While Retaining Flag And Anthem Ban

Russia has faced sweeping sporting sanctions since the invasion of Ukraine in 2022.

ANTHEMIOCHealthcareOil Gas & Consumable Fuels

Read full story

Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr

positive

ET Markets - Industry 22d ago

Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr

Global investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a 3 percent stake in Anthem Biosciences. The deal, valued at Rs 1,275 crore, saw promoter Aruna Ganesh exit the company. This significant transaction reshapes the promoter's holding in the integrated Contract Research, Development and Manufacturing Organisation.

ANTHEMAUTOIETFCOMMOIETFECAPINSUREFINIETFFMCGIETFGICREGLOBALGODIGITGSEC10IETFHEALTHIETFICICIB22ICICIGIICICIPRULIINFRAIETFIREDAITIETFMAKEINDIAMANUFGBEESMETALIETFMIDCAPIETFMOM30IETFMOMGFNEXT50IETFOILIETFPSUBNKIETFSILVERIETFVAL30IETFConsumer ServicesFinancial Services

Read full story

Anthem Biosciences shares rise 4% after equity worth ₹1,275 crore changes hands in block deal

neutral

CNBC TV18 - Markets 23d ago

Anthem Biosciences shares rise 4% after equity worth ₹1,275 crore changes hands in block deal

CNBC-TV18 had reported on Wednesday that a block deal was likely in the stock, with promoter group entity Aruna Ganesh expected to be the seller. Aruna Ganesh was looking to offload up to a 3.05% stake in the company through the transaction, valued at around ₹1,314 crore.

ANTHEMHealthcare

Read full story

ANTHEM

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Recent MA Crossovers

Stop Loss Levels

Fixed Risk

Technical Levels

Moving Averages

Financials

Financial Analysis

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Corporate Actions

Announcements

Board Meetings

Corporate Events

Shareholding Pattern

Shareholding Pattern

Current Distribution

Trend (Last 2 Qtrs)

Latest News

News for ANTHEM

IOC Allows Russia's Olympic Return While Retaining Flag And Anthem Ban

Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr

Anthem Biosciences shares rise 4% after equity worth ₹1,275 crore changes hands in block deal

Frequently Asked Questions

What is the current share price of Anthem Biosciences Limited (ANTHEM)?

What is the technical sentiment for ANTHEM stock?

What is the 52-week high and low for Anthem Biosciences Limited?

Which sector does Anthem Biosciences Limited belong to?

What is the market capitalization of ANTHEM?